title: Therapy-related acute myelogenous leukemia in a hydroxyurea-treated patient with sickle cell anemia.
authors.forename: James G
authors.initials: JG
authors.lastname: Taylor
authors.forename: Deepika S
authors.initials: DS
authors.lastname: Darbari
authors.forename: Deepika S
authors.initials: DS
authors.lastname: Darari
authors.forename: Irina
authors.initials: I
authors.lastname: Maric
authors.forename: Zachariah
authors.initials: Z
authors.lastname: McIver
authors.forename: Diane C
authors.initials: DC
authors.lastname: Arthur
mesh_terms: D000328:Adult; D000755:Anemia, Sickle Cell / Q000150:complications* / Q000188:drug therapy*; D000986:Antisickling Agents / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D006918:Hydroxyurea / Q000009:adverse effects / Q000627:therapeutic use*; D015470:Leukemia, Myeloid, Acute / Q000175:diagnosis / Q000209:etiology*; D008297:Male
chemical_list: D000986:Antisickling Agents; D006918:Hydroxyurea
references.citation: Am J Hematol. 2010 Jun;85(6):403-8
references.pmid: 20513116
references.citation: Semin Thromb Hemost. 2006 Jun;32(4 Pt 2):417-21
references.pmid: 16810617
references.citation: Blood. 2009 Jul 30;114(5):937-51
references.pmid: 19357394
references.citation: Ann Intern Med. 2008 Jun 17;148(12):939-55
references.pmid: 18458272
references.citation: Br J Haematol. 2003 Oct;123(2):368-9
references.pmid: 14531924